content top

Clinical Experience of Ocriplasmin for Vitreomacular Traction and MH

Purpose: To evaluate the anatomical and functional results after ocriplasmin (JETREA, ThromboGenics NV, Iselin, NJ, USA) injection in patients with vitreomacular traction (VMT) with or without macular hole (MH). Methods: Fifteen prospective patients with VMT were treated with a single ocriplasmin injection and followed-up at baseline, 1 week, 1, 3 and 6 months. ETDRS best-corrected visual acuity (BCVA), intraocular pressure and...

Read More

Outcome of IVT of Ocriplasmin for Symptomatic Vitreomacular Adhesion

SCIENTIFIC POSTER 2016_Outcome of IVTY of Ocriplasmin for Symptomatic Vitreomacular Adhesion Mostafa Elgohary Purpose: To evaluate the rate of release of vitreomacular adhesion (VMA), anatomical changes and visual outcome following intravitreal ocriplasmin injection for the treatment of symptomatic VMA with and without full-thickness macular hole (FTMH). Methods: This is a retrospective, interventional, case-series of 12 eyes of 11...

Read More

Outcome of Vitreomacular Traction Syndrome: Natural Course vs Vitrectomy vs Ocriplasmin

SCIENTIFIC POSTER 2016_Outcome of Vitreomacular Traction Syndrome Natural Course vs Vitrectomy vs Ocriplasmin Constantinos Demosthenous Purpose: Posterior Vitreous Detachment (PVD) is a common eye condition related with the normal aging of vitreous gel. However, the presence of persistent vitreomacular adhesions exerting tractional forces may be associated with the disruption of foveal anatomy thereby causing symptoms of visual...

Read More

Comparison of Clinical Characteristics in Myopic Traction Maculopathy with and Without MH

So Hyun Bae_SCIENTIFIC POSTER 2015 Purpose: To compare the clinical characteristics of myopic traction maculopathy (MTM) with and without macular hole (MH). Methods: This retrospective study included the patients with MTM who underwent vitrectomy. The eyes were subdivided into 2 groups based on the presence of MH. Clinical features were assessed including age, sex, axial length, visual acuity, posterior staphyloma, chorioretinal atrophy and...

Read More

The Efficacy of Ocriplasmin in the Treatment of Symptomatic Vitreomacular Traction

Katarzyna Michalska-Malecka_SCIENTIFIC POSTER 2015 The Aim: The aim of the research was to evaluate the influence of ocriplasmin intravitreal injection on the changes in vitreomacular traction and on improvements in visual acuity. Patients & Methods: The analysis included patients who were treated in the University Centre of Ophthalmology and Oncology, Independent Public Clinical Hospital, Medical University of Silesia in Katowice, and...

Read More

My Tips for Improved Outcomes in Macular Hole Surgery

The authors present “My Way” for Macular Hole surgical approach. Reports in the literature are largely retrospective, making direct comparison of surgical strategies and methods difficult.The authors expose their tips and rationale for surgical approach that they believe is a contribution to improved outcomes. Tip 1 – Idiopathic Macular Holes are actually secondary to Vitreo Macular Traction (VMT) Tip 2 – In macular holes...

Read More
content top